WE vs IB Nimble

The WE-ACT app is designed to promote better communication between cancer patients and their employers and between cancer patients and their healthcare teams. This app contains helpful information for cancer patients to use during and after treatment. Victoria Blinder, MD, MSc, is a board certified medical oncologist at Memorial Sloan Kettering Cancer Center with a practice that is dedicated to the treatment of patients with cancer. Her research focuses on understanding and addressing disparities in cancer outcomes. She is the primary investigator of the WE-ACT Study, which tests an early version of this mobile health app designed to help cancer patients keep their jobs during and after treatment. Medical Disclosure: This mobile application (“App”) is operated by Memorial Sloan Kettering Cancer Center (“MSK”) and is intended only for users who consented to take part in the research study named Talking to Employers and Medical Staff About Work (WE-ACT). THIS APP IS NOT TO BE USED AS A SUBSTITUTE FOR MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT OF ANY HEALTH CONDITION OR PROBLEM. ANY QUESTIONS REGARDING YOUR OWN HEALTH SHOULD BE ADDRESSED TO YOUR OWN PHYSICIAN OR OTHER HEALTHCARE PROVIDER. The App may contain links to external websites or mobile applications that are not owned or operated by MSK (the “External Content”). MSK does not control External Content and we are not responsible for the content or performance of those sites. A link to External Content does not imply any agreement with or endorsement of the External Content or any association with the owner or operators of the External Content. You are responsible for viewing and abiding by the terms and conditions of use and the privacy statements of the External Content.

IB Nimble provides access to a set of professionally recognized diagnostic algorithms for oncologic diseases. It also allows asynchronous communication between clinical experts, facilitating patient care. IB Nimble provides real-time, evidence-based treatment plans which can reduce length of hospital stay, costs, and care delays for a critical patient population. The smart technology embedded in IB Nimble enhances cancer treatment center capabilities and physicians' expertise to make healthcare more efficient, thus enhancing patient health and well-being.